Qube Research & Technologies (QRT)
COCP icon

Qube Research & Technologies (QRT)’s Cocrystal Pharma COCP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,210
Closed -$28K – 2581
2021
Q3 		$28K Buy
+2,210
New +$29.2K ﹤0.01% 1929
2021
Q2 		– Sell
-1,439
Closed -$24K – 2333
2021
Q1 		$24K Sell
1,439
-6,896
-83% -$140K ﹤0.01% 1813
2020
Q4 		$136K Sell
8,335
-10,589
-56% -$147K ﹤0.01% 1604
2020
Q3 		$211K Buy
18,924
+15,546
+460% +$284K ﹤0.01% 1375
2020
Q2 		$62K Buy
+3,378
New +$41.4K ﹤0.01% 1571

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s COCP Position: Q4 2021 in Review

Qube Research & Technologies (QRT) sold out of Cocrystal Pharma (COCP) in Q4 2021, closing a stake of 2,210 shares — an estimated $28K sold.

Qube Research & Technologies (QRT) first reported a position in COCP in Q2 2020 and held it in 5 quarters. The position peaked at $211K in Q3 2020. 35 funds tracked by Wall St. Rank hold COCP as of Q4 2021.

  • Qube Research & Technologies (QRT) reported no remaining Cocrystal Pharma position as of Q4 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,210 Cocrystal Pharma shares in Q4 2021, an estimated $28K.
  • Qube Research & Technologies (QRT) first reported a position in Cocrystal Pharma in Q2 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Cocrystal Pharma position peaked at $211K in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2021, filed 1 Feb 2022.